We are live on ! Find out more
SONM icon

DNA X Inc
SONM

15 hedge funds and large institutions have $373K invested in DNA X Inc in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

25% more funds holding

Funds holding: 12 → 15 (+3)

8% more capital invested

Capital invested by funds: $346K → $373K (+$26.7K)

0.01% less ownership

Funds ownership: 0.02% → 0.01% (-0.01%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$142K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$28.1K
3
State Street
State Street
Massachusetts
+$16.1K
4
Northern Trust
Northern Trust
Illinois
+$11.8K
5
TSS
Two Sigma Securities
New York
+$9.81K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$76.1K
2
Millennium Management
Millennium Management
New York
-$42.1K
3
Citigroup
Citigroup
New York
-$11.9K
4
Morgan Stanley
Morgan Stanley
New York
-$7.33K
5
SG
StoneX Group
New York
-$6.34K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
1
Bank of New York Mellon
New York
$110K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$103K +$142K +1,144 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$37K – – –
VF
4
Virtu Financial
New York
$24K +$2.73K +22 +9%
Millennium Management
5
Millennium Management
New York
$20K -$42.1K -339 -60%
Vanguard Group
6
Vanguard Group
Pennsylvania
$20K +$28.1K +226 New
State Street
7
State Street
Massachusetts
$12K +$16.1K +130 New
Citigroup
8
Citigroup
New York
$9K -$11.9K -96 -49%
Northern Trust
9
Northern Trust
Illinois
$9K +$11.8K +95 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$7K -$76.1K -613 -89%
TSS
11
Two Sigma Securities
New York
$7K +$9.81K +79 New
WAP
12
Wealthcare Advisory Partners
Pennsylvania
$5K – – –
Fidelity Investments
13
Fidelity Investments
Massachusetts
$5K +$6.71K +54 +2,700%
SFI
14
Susquehanna Fundamental Investments
Pennsylvania
$5K +$7.2K +58 New
SG
15
StoneX Group
New York
– -$6.34K -64 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$7.33K -59 Closed
Wells Fargo
17
Wells Fargo
California
– -$124 -1 Closed

SONM Hedge Fund Activity: Q3 2022 in Review

15 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q3 2022, worth a combined $373K — up 7.7% from $346K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new SONM positions and 3 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $142K. The largest seller was Susquehanna International Group, cutting an estimated $76.1K.

  • 15 institutional investors held DNA X Inc (SONM) as of Q3 2022, up from 12 in Q2 2022.
  • Funds reported $373K of DNA X Inc stock for Q3 2022, up 7.7% quarter-over-quarter.
  • 6 funds opened new DNA X Inc positions in Q3 2022 and 3 closed out, a net change of +3 holders.
  • The largest DNA X Inc buyer in Q3 2022 was Renaissance Technologies, an estimated $142K added.
  • The largest DNA X Inc seller in Q3 2022 was Susquehanna International Group, an estimated $76.1K sold.

Based on aggregated 13F filings for Q3 2022.